Jardiance
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0597-0153 -
Package NDC
0597-0153-07 -
Package NDC
0597-0153-30 -
Package NDC
0597-0153-37 -
Package NDC
0597-0153-90 -
Application number
NDA204629 -
SPL ID
8979dbeb-3cf4-4548-93cc-82a911b58a26 -
SPL set ID
faf3dd6a-9cd0-39c2-0d2e-232cb3f67565 -
UNII
HDC1R2M35U
What the source publishes
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Active ingredients
- Empagliflozin
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Jardiance",
"splId": "8979dbeb-3cf4-4548-93cc-82a911b58a26",
"labels": [
{
"setId": "faf3dd6a-9cd0-39c2-0d2e-232cb3f67565",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=faf3dd6a-9cd0-39c2-0d2e-232cb3f67565",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=faf3dd6a-9cd0-39c2-0d2e-232cb3f67565"
}
],
"routes": [
"ORAL"
],
"labeler": "Boehringer Ingelheim Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": true,
"description": "1 BOTTLE in 1 CARTON (0597-0153-07) / 7 TABLET, FILM COATED in 1 BOTTLE",
"package_ndc": "0597-0153-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20140801"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (0597-0153-30)",
"package_ndc": "0597-0153-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20140801"
},
{
"sample": false,
"description": "30 BLISTER PACK in 1 CARTON (0597-0153-37) / 1 TABLET, FILM COATED in 1 BLISTER PACK",
"package_ndc": "0597-0153-37",
"identifierStatus": "well-formed",
"marketing_start_date": "20140801"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED in 1 BOTTLE (0597-0153-90)",
"package_ndc": "0597-0153-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20140801"
}
],
"productId": "0597-0153_8979dbeb-3cf4-4548-93cc-82a911b58a26",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "0597-0153",
"deaSchedule": null,
"genericName": "Empagliflozin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "EMPAGLIFLOZIN",
"strength": "25 mg/1"
}
],
"applicationNumber": "NDA204629",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140801",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000187059",
"N0000187058"
],
"unii": [
"HDC1R2M35U"
],
"spl_set_id": [
"faf3dd6a-9cd0-39c2-0d2e-232cb3f67565"
],
"pharm_class_epc": [
"Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Sodium-Glucose Transporter 2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Boehringer Ingelheim Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0597-0153_8979dbeb-3cf4-4548-93cc-82a911b58a26"